Szela Mary T

Szela Mary T is listed in filings as CEO AND PRESIDENT at TriSalus Life Sciences, Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including purchase activity and sale activity. Recent filings connect the profile to TriSalus Life Sciences, Inc. (TLSI), Absci Corporation (ABSI), Omega Therapeutics, Inc. (OMGA), and Kura Oncology, Inc. (KURA). The current snapshot covers public activity from Jun 21, 2024 to Jun 8, 2026. Reported amounts are shown as $24.9K to $6.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.